Skip to main content

ADVERTISEMENT

Podcasts

Headshot of Jeffrey Dunn, PharmD, MBA, Cooperative Benefits Group
Podcasts
12/21/2022
Jeffrey Dunn, PharmD, MBA, chief clinical officer, Cooperative Benefits Group, discusses the rationale driving coverage for new and existing drugs and shares how US stakeholders account for metrics like quality of life.
Jeffrey Dunn, PharmD, MBA, chief clinical officer, Cooperative Benefits Group, discusses the rationale driving coverage for new and existing drugs and shares how US stakeholders account for metrics like quality of life.
Jeffrey Dunn, PharmD, MBA, chief...
12/21/2022
First Report Managed Care
Michael Hall, MD, Fox Chase Cancer Center
Podcasts
12/20/2022
Michael Hall, MD, reviews his presentation from the 2022 Great Debates & Updates in Gastrointestinal Malignancies virtual meeting, on genetic testing for gastrointestinal cancers.
Michael Hall, MD, reviews his presentation from the 2022 Great Debates & Updates in Gastrointestinal Malignancies virtual meeting, on genetic testing for gastrointestinal cancers.
Michael Hall, MD, reviews his...
12/20/2022
Oncology
Headshot of Alan Vernon, CQ Fluency, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
12/20/2022
Alan Vernon, vice president of health care solutions, CQ Fluency, reviews how many people in the United States do not speak English as their primary language and offers advice for payers and providers to keep patients engaged in their care.
Alan Vernon, vice president of health care solutions, CQ Fluency, reviews how many people in the United States do not speak English as their primary language and offers advice for payers and providers to keep patients engaged in their care.
Alan Vernon, vice president of...
12/20/2022
Integrated Healthcare Executive
Bruce Sands
Podcast
12/19/2022
Dr Sands provides an overview of the VEGA study, the first of its kind to combine 2 biologic agents to attempt to achieve higher rates of remission among patients with ulcerative colitis.
Dr Sands provides an overview of the VEGA study, the first of its kind to combine 2 biologic agents to attempt to achieve higher rates of remission among patients with ulcerative colitis.
Dr Sands provides an overview of...
12/19/2022
Advances in Inflammatory Bowel Disease Network
sebag cavins
Podcasts
12/15/2022
In the second episode of this series, the guests share even more insights on pearls and techniques inf first MTPJ salvage, starting with postoperative considerations.
In the second episode of this series, the guests share even more insights on pearls and techniques inf first MTPJ salvage, starting with postoperative considerations.
In the second episode of this...
12/15/2022
Podiatry Today
Violari and Gandhi
Podcast
12/13/2022
In the latest offering from the SIO Corner, Dr Ripal Gandhi discusses his experiences building a successful Y-90 program along with recent advancements in Y-90 radioembolization.
In the latest offering from the SIO Corner, Dr Ripal Gandhi discusses his experiences building a successful Y-90 program along with recent advancements in Y-90 radioembolization.
In the latest offering from the...
12/13/2022
IO Learning
Headshot of Alex Bacchetti, AVIA, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
12/13/2022
Alex Bacchetti, executive lead of the Center of Operational Transformation, AVIA, shares staffing ideas and technological solutions for health systems to improve recruiting and alleviate burnout now that the pandemic has exacerbated the labor...
Alex Bacchetti, executive lead of the Center of Operational Transformation, AVIA, shares staffing ideas and technological solutions for health systems to improve recruiting and alleviate burnout now that the pandemic has exacerbated the labor...
Alex Bacchetti, executive lead...
12/13/2022
Integrated Healthcare Executive
Matthew Zirwas, MD
Podcasts
12/13/2022
In this NEA feature podcast, Drs Chovatiya and Zirwas discuss treatment strategies for AD.
In this NEA feature podcast, Drs Chovatiya and Zirwas discuss treatment strategies for AD.
In this NEA feature podcast, Drs...
12/13/2022
The Dermatologist
Walter Maksymowych
Conference Coverage
12/13/2022
Dr Maksymowych discusses the results of a randomized clinical trial of upadacitinib vs placebo among patients with radiographic and nonradiographic axial spondyloarthritis.
Dr Maksymowych discusses the results of a randomized clinical trial of upadacitinib vs placebo among patients with radiographic and nonradiographic axial spondyloarthritis.
Dr Maksymowych discusses the...
12/13/2022
Rheumatology & Arthritis
Headshot of Omar Sinno, UCB, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
12/08/2022
Omar Sinno, MD, MBA, medical lead, rare disease, UCB, walks through the findings and implications of the phase 3 RAISE study which evaluated zilucoplan for the treatment of patients with myasthenia gravis.
Omar Sinno, MD, MBA, medical lead, rare disease, UCB, walks through the findings and implications of the phase 3 RAISE study which evaluated zilucoplan for the treatment of patients with myasthenia gravis.
Omar Sinno, MD, MBA, medical...
12/08/2022
First Report Managed Care